Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Humana

2 Health Insurance Stocks to Buy in October and 1 to Avoid

The raging inflation is expected to increase healthcare expenditure significantly. This, along with heightened health awareness in this post-pandemic era, should drive the demand for health insurance. So, investing in fundamentally strong health insurance stocks, UnitedHealth Group (UNH) and Humana Inc. (HUM), could be wise. On the other hand, Clover…

Top Financial Media Stories Friday, September 23: Apple Resolves iPhone 14 Pro Camera Glitch, Credit Suisse Shares Tumble As It Looks For Capital Infusion, Boeing Penalized $200M For Misleading About 737 MAX Safety And More..

Top Financial Media Stories Friday, September 23: Apple Resolves iPhone 14 Pro Camera Glitch, Credit Suisse Shares Tumble As It Looks For Capital Infusion, Boeing Penalized $200M For Misleading About 737 MAX Safety And More..

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This Is What Whales Are Betting On Humana

Someone with a lot of money to spend has taken a bearish stance on Humana (NYSE:HUM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

3 Stocks to Target as Investors Rotate Back Into the Health Care Sector

Investors seem to show renewed interest in the healthcare sector as COVID-19 cases rise worldwide and portfolio resiliency amid the uncertain macro environment. So, fundamentally strong healthcare stocks Cigna Corp (CI), Centene Corp (CNC), and Humana (HUM) might be solid buys now. Read on.

Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 11.85% on an annualized basis producing an average annual return of 18.87%. Currently, Humana has a market capitalization of $59.29 billion.

What Are Whales Doing With Humana

A whale with a lot of money to spend has taken a noticeably bullish stance on Humana. Looking at options history for Humana (NYSE:HUM) we detected 10 strange trades.

inkl

Read news from The Economist, FT, and more,
with one subscription

Where Humana Stands With Analysts

Where Humana Stands With Analysts

Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter:

How Is The Market Feeling About Humana?

How Is The Market Feeling About Humana?

Humana's (NYSE:HUM) short percent of float has risen 8.42% since its last report. The company recently reported that it has 1.29 million shares sold short, which is 1.03% of all regular shares that are available for trading.

3 Defensive Stocks to Outperform in this Bear Market

3 Defensive Stocks to Outperform in this Bear Market

While the stock market has entered a bear phase following the release of multi-decade high inflation data, the health insurance industry could survive the downturn because of the near-inelastic demand for health coverage. Therefore, investors looking to dodge a market downturn could bet on fundamentally sound health insurance stocks Anthem…

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,500 Today

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,500 Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.8% on an annualized basis producing an average annual return of 17.56%. Currently, Humana has a market capitalization of $53.98 billion.

How Is The Market Feeling About Humana?

How Is The Market Feeling About Humana?

Humana's (NYSE:HUM) short percent of float has risen 6.25% since its last report. The company recently reported that it has 1.50 million shares sold short, which is 1.19% of all regular shares that are available for trading.

HP And 3 Other Stocks Insiders Are Selling

HP And 3 Other Stocks Insiders Are Selling

US stocks closed sharply higher on Wednesday after the Federal Reserve raised its target fed funds rate by 0.5%. Investors, meanwhile, focused on some notable insider trades.

Medicare surprise: Drug plan prices touted during open enrollment can rise within a month

Something strange happened between the time Linda Griffith signed up for a new Medicare prescription drug plan during last fall’s enrollment period and when she tried to fill her first prescription in January.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Drug plan prices touted during Medicare open enrollment can rise within a month

Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.

If You Invested $1000 In Humana 20 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.96% on an annualized basis producing an average annual return of 17.93%. Currently, Humana has a market capitalization of $54.86 billion.

Expert Ratings for Humana

Over the past 3 months, 6 analysts have published their opinion on Humana (NYSE:HUM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Humana's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Humana (NYSE:HUM) earned $930.00 million, a 7253.85% increase from the preceding quarter. Humana also posted a total of $24.08 billion in sales, a 13.59% increase since Q4.

Get all your
news in one place.

100's of premium titles.
One news app.

Humana Q1 Earnings Beats Expectations, Raises FY22 Profit Guidance

Humana Inc (NYSE:HUM) has posted Q1 adjusted sales of $24.08 billion, beating the consensus of $23.51 billion. The benefits expense ratio increased from 86.4% to 85.9%, and the operating cost ratio increased from 12% to 9.7%. Humana posted an adjusted EPS of $8.04, beating the consensus of $6.78 and $6.38 posted a…

Humana: Q1 Earnings Insights

Humana (NYSE:HUM) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Humana to Offload Substantial Stake In Kindred At Home Hospice & Personal Care Divisions

Humana Inc (NYSE:HUM) has agreed to divest a majority interest in the Hospice and Personal Care divisions of Humana's Kindred at Home (KAH Hospice) subsidiary to Clayton, Dubilier & Rice (CD&R). The divisions include patient-centered services for Hospice, Palliative, Community, and Personal Care. Humana had previously indicated its intent to divest a majority…

If You Invested $100 In Humana 10 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 10 years by 5.55% on an annualized basis producing an average annual return of 18.03%. Currently, Humana has a market capitalization of $59.08 billion.

Tribune News Service

Denunciantes dicen que las aseguradoras de salud estafan a Medicare para ganar miles de millones

Teresa Ross llevaba meses planteando objeciones en el trabajo cuando sus jefes trajeron a un psicólogo con la esperanza de hacerle cuestionar su propia cordura.

UBS Upgrades Rating to Buy for Humana, Raises Price Target To $520

UBS upgraded its rating of Humana (NYSE:HUM) to Buy with a price target of $520.00, changing its price target from $486.00 to $520.00. Shares of Humana are trading up 2.2% over the last 24 hours, at $458.92 per share. A move to $520.00 would account for a 13.31% increase from…

Tribune News Service

Whistleblowers say health insurers are scamming Medicare to make billions

Teresa Ross had been raising objections at work for months when her bosses brought in a psychologist hoping to make her question her own sanity.

1 … 3 4 5 6

People

Dipanjan BanchurSince

Chiquita BrooksLaSure

Stacie Dusetzina

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Justice Department

Department of Justice

Wall Street Journal

UnitedHealthcare

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Prescription Drug

Places

359,360 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play